Pharmacorp Rx Inc. (TSE:PCRX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PharmaCorp Rx Inc. has agreed to purchase a 90% interest in a Western Canadian pharmacy for $2.2 million, aiming to strengthen its market presence and maintain high service standards. The deal, planned to close by August 30, 2024, includes the continued involvement of the previous owners, with one becoming the managing pharmacist under a long-term agreement.
For further insights into TSE:PCRX stock, check out TipRanks’ Stock Analysis page.